Atlas Trials

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

Clinical trial NCT04983537 · UNKNOWN

Trial details

NCT number
NCT04983537
Sponsor
Ministerio de Salud de Ciudad Autónoma de Buenos Aires
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19 Vaccines
Start date
2021-07-26
Primary completion
2021-09-26
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.